NDRA - ENDRA Life Sciences Inc.

3.64
-0.210   -5.769%

Share volume: 53,146
Last Updated: 03-04-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$3.85
-0.21
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
35%
Profitability 25%
Dept financing 23%
Liquidity 47%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-7.14%
1 Month
-3.96%
3 Months
-38.93%
6 Months
-14.75%
1 Year
-4.96%
2 Year
217.02%
Key data
Stock price
$3.64
P/E Ratio 
0.00
DAY RANGE
$3.44 - $3.81
EPS 
-$15.21
52 WEEK RANGE
$2.90 - $11.96
52 WEEK CHANGE
-$0.27
MARKET CAP 
4.050 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
0.03
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$587,253
AVERAGE 30 VOLUME 
$239,060
Company detail
CEO: Francois Michelon
Region: US
Website: endrainc.com
Employees: 20
IPO year: 2017
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

ENDRA Life Sciences Inc. develops thermo-acoustic enhanced ultrasound technology. Technology transmits sound waves, which bounce off tissues, organs, and blood in the body. Thermoablative surgery, vascular imaging, and tissue perfusion technologies also offer diagnostic imaging technologies.

Recent news